Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion
02 Jul 2024 //
BIOSPECTRUM ASIA
LIB & Partner Hasten Announce Lerodalcibep Clinical Trial
19 Mar 2024 //
BUSINESSWIRE
LIB Therapeutics and Hasten Company Announce $325 Million Collaboration
12 Sep 2023 //
BUSINESSWIRE
Hasten acquires commercial rights in China for Roche`s antibiotic Rocephin
05 May 2023 //
BIOSPECTRUMASIA
Hasten Acquires Commercial Rights in China for Roche`s Antibiotic Rocephin®
04 May 2023 //
PR NEWSWIRE